MIT Engineers Develop Nanoparticles for Personalized Cancer Vaccines

Engineers at MIT have created novel nanoparticles capable of delivering personalized cancer vaccines. These particles, based on a modified bacteriophage, can be coated with customized doses of cancer antigens to provoke a strong immune response against tumors. The modular design allows for patient-specific vaccines, demonstrating potential for preventing colon tumors in mice and offering a significant advance in targeted cancer immunotherapy.